The Europe Endometriosis Market would witness market growth of 11.4% CAGR during the forecast period (2022-2028).
A laparoscopy is typically used to confirm endometriosis. This little procedure entails making a tiny incision beneath the belly button in the abdominal wall while under anesthesia (umbilicus). To view inside, a laparoscope, a thin telescope-like equipment, is put through the skin. The doctor can see areas of endometriosis.
The main goals of treatment are to reduce the discomfort and heavy periods associated with endometriosis, as well as to increase fertility if it has been impacted. Endometriosis can be treated in a number of ways. If the patient's fertility is unaffected by the endometriosis and the symptoms are moderate, therapy may not be desired. About 3 out of 10 times, endometriosis resolves on its own, and symptoms disappear. If symptoms persist or worsen, the patient can always alter their mind and choose endometriosis treatment.
In order to better the lives of patients and boost the economy, the UK government has allocated £790 million to encourage innovations in novel therapies, diagnostics, and medical technology. To enhance the delivery of health and care in a safe manner and better address health issues like cancer treatment and drug error reduction, £25 million will be allocated for patient safety research. Significant funding pledges to advance research in all regions of the nation level the playing field for innovation and address health disparities. Following significant investment to promote ground-breaking experimental medicine research and expand the UK's response to patient safety problems, patients throughout the nation are expected to benefit from novel new medicines and improved health and care service delivery. This will spur market expansion in the Europe region.
The Germany market dominated the Europe Endometriosis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $146.2 million by 2028. The UK market is anticipated to grow at a CAGR of 10.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 12.2% during (2022 - 2028).
Based on Type, the market is segmented into Superficial Peritoneal Lesion, Endometriomas, and Others. Based on Treatment, the market is segmented into Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Endometriosis Market will Hit $2.2 Billion by 2028, at a CAGR of 11.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, Abbott Laboratories, and Consilient Health Limited.
By Type
By Treatment
By Distribution Channel
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 